Latest Leverage News

Galileo Mining has delineated two new PGM target zones at its Mission Sill prospect and uncovered a fresh gold prospect at Callisto South within its Norseman project, setting the stage for expanded drilling campaigns.

Meteoric Resources has secured a secondary listing on the U.S. OTCQB Venture Market, enabling its shares to trade under METOF and enhancing access for U.S. and Brazilian investors without disrupting its ASX presence.

West Cobar Metals is fast-tracking its scandium exploration at the Salazar Project in Western Australia, targeting higher-grade zones with aircore drilling planned for late 2026 alongside advancing metallurgical testwork.

Caspin Resources has revealed promising new exploration targets at its Bygoo Tin Project in NSW, alongside ongoing drilling at the Kelpie Deposit, pointing to significant district-scale discovery potential near the historic Ardlethan Mine.

Contact Energy (ASX:CEN) posted a 62% jump in FY26 net profit to NZD 423 million, driven by its Manawa acquisition and a near 98% renewable generation mix, while committing to net zero emissions by 2035.

Theta Gold Mines is issuing 32.8 million shares at 18 cents each to settle a longstanding US$11.6 million unsecured loan, adjusting its capital structure without shareholder approval.

Metcash Limited posted a steady FY26 performance, with group revenue rising to $19.6 billion and EBITDA up 1.9%, driven by growth in Food and digital channels despite challenges in Hardware.

Patriot Resources has expanded its silver-gold footprint in southern Peru by staking the Tassa 5 tenement, increasing its landholding by 50% and pushing the mineralised corridor further south adjacent to its 31.4Moz AgEq inferred resource.

RocketDNA Ltd has secured a $1 million contract extension from BHP Mitsubishi Alliance to continue its autonomous drone operations in the Bowen Basin until October 2026, reinforcing its position in mining tech.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.